Meeting
2023 ASCO Genitourinary Cancers Symposium
A multicenter prospective validation study of the 3-cm cut-off in stage I seminoma (S3MI-PT).
Authors
Mario Fontes-Sousa
Hospital CUF Tejo, Lisboa, Portugal
Mario Fontes-Sousa , Helena Magalhães , Ricardo Leão , André Mansinho , Mariana Malheiro , Alina Rosinha , Margarida Carrolo , Paula Borralho , Joaquina Mauricio , Margarida Brito , Jose Luis C. Passos-Coelho , Antonio Quintela
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr TPS435)
DOI
10.1200/JCO.2023.41.6_suppl.TPS435
Abstract #
TPS435
Poster Bd #
N17
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of DAZL expression with risk of recurrence in clinical stage 1 testicular germ cell tumors.
First Author: Alok Tewari
Poster
2016 Genitourinary Cancers Symposium
Optimization of an imaging protocol for stage I seminoma surveillance based on variations in relapse location over time.
First Author: Andrew McPartlin
Poster
2011 Genitourinary Cancers Symposium
Surveillance for stage I testicular seminoma at a single institution in Japan: Retrospective analysis of prognostic factors for relapse.
First Author: Ken-Ichi Kakimoto
Poster
2023 ASCO Annual Meeting
Prognostic factors for relapse in patients with clinical stage I testicular seminoma: A nationwide, population-based cohort study.
First Author: Thomas Wagner